2-fluoropropionyl-labeled pegylated dimeric RGD peptide

From WikiMD's free health, diet & wellness encyclopedia
Jump to navigation Jump to search

A radiopharmaceutical agent comprised of a pegylated dimeric arginine-glycine-aspartic acid (RGD)-based peptide labeled with 2-fluoropropionyl, with potential alphaVbeta3 integrin imaging activity upon positron emission topography (PET). The RGD moiety of 2-fluoropropionyl-labeled pegylated dimeric RGD peptide targets and binds to alphaVbeta3 integrin.

How does it work?

Upon PET imaging, alphaVbeta3 integrin-expressing tumor cells can be visualized and expression levels can be quantified. Compared to other fluorine F 18 labeled RGD-containing peptides, this agent shows increased affinity to alphaVbeta3 integrin, enhanced tumor uptake as well as improved pharmacokinetics. alphaVbeta3 integrin, overexpressed on certain tumor cells and tumor endothelial cells, plays a key role in angiogenesis, tumor proliferation and survival.

Learn more about 2-fluoropropionyl-labeled pegylated dimeric RGD peptide

Latest research - 2-fluoropropionyl-labeled pegylated dimeric RGD peptide

PubMed
Clinical trials

External links

Wikipedia
Medicine icon
Medicine icon

This WikiMD article 2-fluoropropionyl-labeled pegylated dimeric RGD peptide is a stub. If you are familiar with the topic 2-fluoropropionyl-labeled pegylated dimeric RGD peptide, you can help us. Paid editors welcome!

 

2-fluoropropionyl-labeled pegylated dimeric RGD peptide is part of WikiMD's free ^articles!

^2-fluoropropionyl-labeled pegylated dimeric RGD peptide (article) is provided for informational purposes only. No expressed or implied warranties as to the validity of content.
WikiMD is not a substitute for professional advice. By accessing and using WikiMD you agree to the terms of use.
Templates etc. when imported from Wikipedia, are licensed under CC BY-SA 3.0. See full disclaimers.
W8MD weight loss logo

Ad. Tired of being overweight?. W8MD's physician weight loss program can HELP. Tele medicine available